Having confirmed E2 enrichment in cervical SCC tumours, we next assessed which of the infiltrating cell types expressed the corresponding oestrogen receptor - ERα and might be sensitive to modulation by E2 exposure. The gene discussed is ESR1; the disease is neoplasm.